Skip to content

Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome

Effects of Carboxymethylcellulose Artificial Tears on the Eye Microbiome: a Randomized, Controlled, Double-Blind Study

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05292755
Enrollment
80
Registered
2022-03-23
Start date
2022-04-22
Completion date
2022-07-01
Last updated
2023-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye Syndromes

Brief summary

Carboxymethylcellulose (CMC), a common component in artificial tears, has been shown to modify the gut microbiome. The study is examining its effects on the eye microbiome, which may have implications on ocular disease and artificial tear choice. The study will administer artificial tears containing CMC to the treatment group and artificial tears without CMC to the control group. Surveys and conjunctival swabs will be collected before and after treatment for bacterial genome sequencing and analyzed by R statistical packages.

Interventions

DRUGCarboxymethylcellulose (CMC) Artificial Tears

A pack of 21 vials of artificial tears containing carboxymethylcellulose 0.5% will be given to subjects in the treatment group.

DRUGPreservative-free, CMC-free Artificial Tears (control)

A pack of 21 vials of artificial tears containing 0.4% polyethylene glycol 400 and 0.3% propylene glycol will be given to subjects in the control group.

Sponsors

University of Florida
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults above age 18 of either sex who can self-administer artificial tears and return for follow-up at the UF Oaks Eye Clinic.

Exclusion criteria

* Individuals with active eye infections or have prosthetic eyes. * Are immunocompromised, or are diagnosed with autoimmune diseases or malignant neoplasms about the eye. * Individuals who take immunomodulatory therapy, steroids, antibiotics, medicated eyedrops, or are already using CMC eyedrops within 1 week of the study will also be excluded.

Design outcomes

Primary

MeasureTime frameDescription
Species RichnessAssessed at day 1 and day 7, day 7 reported.Sampled 16S rRNA sequences were organized into 'operational taxonomic units' (OTUs) at a 97% sequence similarity threshold, and a phylogenetic tree was constructed from sampled OTUs using the QIIME2 bioinformatics platform. Faith's phylogenetic diversity was used as a measure of species richness, calculated as the sum of all phylogenetic tree branch lengths using the QIIME2 faith\_pd plugin. The units for this measure are the number of nucleotide substitutions (phylogenetic distance, i.e. length) per branch, which is a scale measure from zero to infinity. Zero indicates a completely homogenous sample, and higher scores indicate greater species richness.
Species DiversityAssessed at day 1 and day 7, day 7 reported.Sampled 16S rRNA sequences were organized into 'operational taxonomic units' (OTUs) at a 97% sequence similarity threshold. Shannon's diversity index was used as a measure of species diversity, calculated as the sum of -p/ln(p), where p is the proportion of the sample made up of each OTU using the QIIME2 shannon\_pd plugin. This measure is a unitless scale proportion ranging from zero to infinity. Zero indicates a completely homogenous sample, and higher scores indicate greater species diversity.
Beta Diversity (Unweighted UniFrac)Assessed at day 1 and day 7, difference between day 1 and day 7 reported.Sampled 16S rRNA sequences were organized into 'operational taxonomic units' (OTUs) at a 97% sequence similarity threshold, and a phylogenetic tree was constructed from sampled OTUs using the QIIME2 bioinformatics platform. Unweighted UniFrac distances were calculated as the number of shared nucleotide substitutions between two samples divided by the number of shared nucleotide substitutions among all samples using the QIIME2 unifrac plugin. The unweighted UniFrac is a unitless scale proportion ranging from zero to one. Greater UniFrac distances indicate greater beta diversity.
Beta Diversity (Weighted UniFrac)Assessed at day 1 and day 7, difference between day 1 and day 7 reported.Sampled 16S rRNA sequences were organized into 'operational taxonomic units' (OTUs) at a 97% sequence similarity threshold, and a phylogenetic tree was constructed from sampled OTUs using the QIIME2 bioinformatics platform. Weighted UniFrac distances were calculated as the number of shared nucleotide substitutions between two samples divided by the number of shared nucleotide substitutions among all samples using the QIIME2 unifrac plugin, with samples weighted by abundance of species. The weighted UniFrac (weighted by number of duplicate OTUs) is a unitless scale proportion ranging from zero to infinity. Greater UniFrac distances indicate greater beta diversity.

Secondary

MeasureTime frameDescription
Ocular Surface Disease Index ScoreAssessed at day 1 and day 7, difference between day 1 and day 7 reported.The Ocular Surface Disease Index (OSDI) is a 12-item scale for the assessment of symptoms related to dry eye disease and their effect on vision. Participants conducted a survey before and after intervention, and the difference will be used as the outcome measure. The OSDI ranges from 0 to 48, and a higher score indicates greater ocular surface dryness. If reporting the difference, a more negative change in OSDI indicates greater improvement in dry eye symptoms. Pairwise Wilcoxon signed rank tests were used to compare changes in OSDI between intervention groups at a two-tailed 95% confidence interval.
Artificial Tear UseAssessed at day 7Patients will be asked 1 week after intervention how many times they administered eye drops each day. This measures compliance with intervention, ranging from zero drops per day to infinite drops per day. If a patient is perfectly compliant, the number of drops should be 3. Mann-U-Whitney tests were used to compare compliance between intervention groups at a two-tailed 95% confidence interval.

Countries

United States

Participant flow

Participants by arm

ArmCount
Carboxymethylcellulose (CMC) Artificial Tears
Refresh brand artificial tears containing 0.5% carboxymethylcellulose will be self-administered three times a day in each eye by the participants for 1 week in the experimental arm. Carboxymethylcellulose (CMC) Artificial Tears: A pack of 21 vials of artificial tears containing carboxymethylcellulose 0.5% will be given to subjects in the treatment group.
40
Preservative-free, CMC-free Artificial Tears
Systane brand artificial tears containing 0.4% polyethylene glycol 400 and 0.3% propylene glycol will be self-administered three times a day in each eye by the participants for 1 week in the control arm. Preservative-free, CMC-free Artificial Tears (control): A pack of 21 vials of artificial tears containing 0.4% polyethylene glycol 400 and 0.3% propylene glycol will be given to subjects in the control group.
40
Total80

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up59

Baseline characteristics

CharacteristicPreservative-free, CMC-free Artificial TearsTotalCarboxymethylcellulose (CMC) Artificial Tears
Age, Continuous40.2 years
STANDARD_DEVIATION 13.8
40.6 years
STANDARD_DEVIATION 15.6
41.1 years
STANDARD_DEVIATION 17.4
Contact lens use10 Participants19 Participants9 Participants
Ocular surgery history10 Participants17 Participants7 Participants
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
40 Participants80 Participants40 Participants
Sex: Female, Male
Female
28 Participants55 Participants27 Participants
Sex: Female, Male
Male
12 Participants25 Participants13 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 400 / 40
other
Total, other adverse events
0 / 400 / 40
serious
Total, serious adverse events
0 / 400 / 40

Outcome results

Primary

Beta Diversity (Unweighted UniFrac)

Sampled 16S rRNA sequences were organized into 'operational taxonomic units' (OTUs) at a 97% sequence similarity threshold, and a phylogenetic tree was constructed from sampled OTUs using the QIIME2 bioinformatics platform. Unweighted UniFrac distances were calculated as the number of shared nucleotide substitutions between two samples divided by the number of shared nucleotide substitutions among all samples using the QIIME2 unifrac plugin. The unweighted UniFrac is a unitless scale proportion ranging from zero to one. Greater UniFrac distances indicate greater beta diversity.

Time frame: Assessed at day 1 and day 7, difference between day 1 and day 7 reported.

ArmMeasureValue (MEDIAN)
Carboxymethylcellulose (CMC) Artificial TearsBeta Diversity (Unweighted UniFrac)0.482 score on a scale
Preservative-free, CMC-free Artificial TearsBeta Diversity (Unweighted UniFrac)0.529 score on a scale
Comparison: Repeated measures Mann-U-Whitney tests were used to compare changes in weighted and unweighted UniFrac distances between intervention groups before and after intervention at a two-tailed 95% confidence interval.p-value: 0.227Repeated measures Mann-U-Whitney
Primary

Beta Diversity (Weighted UniFrac)

Sampled 16S rRNA sequences were organized into 'operational taxonomic units' (OTUs) at a 97% sequence similarity threshold, and a phylogenetic tree was constructed from sampled OTUs using the QIIME2 bioinformatics platform. Weighted UniFrac distances were calculated as the number of shared nucleotide substitutions between two samples divided by the number of shared nucleotide substitutions among all samples using the QIIME2 unifrac plugin, with samples weighted by abundance of species. The weighted UniFrac (weighted by number of duplicate OTUs) is a unitless scale proportion ranging from zero to infinity. Greater UniFrac distances indicate greater beta diversity.

Time frame: Assessed at day 1 and day 7, difference between day 1 and day 7 reported.

ArmMeasureValue (MEDIAN)
Carboxymethylcellulose (CMC) Artificial TearsBeta Diversity (Weighted UniFrac)0.584 score on a scale
Preservative-free, CMC-free Artificial TearsBeta Diversity (Weighted UniFrac)0.593 score on a scale
Primary

Species Diversity

Sampled 16S rRNA sequences were organized into 'operational taxonomic units' (OTUs) at a 97% sequence similarity threshold. Shannon's diversity index was used as a measure of species diversity, calculated as the sum of -p/ln(p), where p is the proportion of the sample made up of each OTU using the QIIME2 shannon\_pd plugin. This measure is a unitless scale proportion ranging from zero to infinity. Zero indicates a completely homogenous sample, and higher scores indicate greater species diversity.

Time frame: Assessed at day 1 and day 7, day 7 reported.

ArmMeasureValue (MEAN)Dispersion
Carboxymethylcellulose (CMC) Artificial TearsSpecies Diversity3.9 score on a scaleStandard Deviation 1.1
Preservative-free, CMC-free Artificial TearsSpecies Diversity4.1 score on a scaleStandard Deviation 1.1
Comparison: ANOVA was used to compare mean Shannon's diversity indices before and after treatment for each intervention group at a two-tailed 95% confidence interval.p-value: 0.224ANOVA
Primary

Species Richness

Sampled 16S rRNA sequences were organized into 'operational taxonomic units' (OTUs) at a 97% sequence similarity threshold, and a phylogenetic tree was constructed from sampled OTUs using the QIIME2 bioinformatics platform. Faith's phylogenetic diversity was used as a measure of species richness, calculated as the sum of all phylogenetic tree branch lengths using the QIIME2 faith\_pd plugin. The units for this measure are the number of nucleotide substitutions (phylogenetic distance, i.e. length) per branch, which is a scale measure from zero to infinity. Zero indicates a completely homogenous sample, and higher scores indicate greater species richness.

Time frame: Assessed at day 1 and day 7, day 7 reported.

ArmMeasureValue (MEAN)Dispersion
Carboxymethylcellulose (CMC) Artificial TearsSpecies Richness11.0 units on a scaleStandard Deviation 2.1
Preservative-free, CMC-free Artificial TearsSpecies Richness11.1 units on a scaleStandard Deviation 3.3
p-value: 0.232ANOVA
Secondary

Artificial Tear Use

Patients will be asked 1 week after intervention how many times they administered eye drops each day. This measures compliance with intervention, ranging from zero drops per day to infinite drops per day. If a patient is perfectly compliant, the number of drops should be 3. Mann-U-Whitney tests were used to compare compliance between intervention groups at a two-tailed 95% confidence interval.

Time frame: Assessed at day 7

ArmMeasureValue (MEAN)Dispersion
Carboxymethylcellulose (CMC) Artificial TearsArtificial Tear Use2.86 eyedrops per dayStandard Deviation 0.81
Preservative-free, CMC-free Artificial TearsArtificial Tear Use2.16 eyedrops per dayStandard Deviation 0.82
Secondary

Ocular Surface Disease Index Score

The Ocular Surface Disease Index (OSDI) is a 12-item scale for the assessment of symptoms related to dry eye disease and their effect on vision. Participants conducted a survey before and after intervention, and the difference will be used as the outcome measure. The OSDI ranges from 0 to 48, and a higher score indicates greater ocular surface dryness. If reporting the difference, a more negative change in OSDI indicates greater improvement in dry eye symptoms. Pairwise Wilcoxon signed rank tests were used to compare changes in OSDI between intervention groups at a two-tailed 95% confidence interval.

Time frame: Assessed at day 1 and day 7, difference between day 1 and day 7 reported.

ArmMeasureValue (MEDIAN)
Carboxymethylcellulose (CMC) Artificial TearsOcular Surface Disease Index Score-1 score on a scale
Preservative-free, CMC-free Artificial TearsOcular Surface Disease Index Score-2 score on a scale

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026